Avanza Fonder Ab Mereo Biopharma Group PLC Transaction History
Avanza Fonder Ab
- $3.86 Trillion
- Q3 2025
A detailed history of Avanza Fonder Ab transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Avanza Fonder Ab holds 38,235 shares of MREO stock, worth $69,587. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,235
Previous 38,235
-0.0%
Holding current value
$69,587
Previous $104 Million
23.99%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MREO
# of Institutions
96Shares Held
99.9MCall Options Held
2.23MPut Options Held
179K-
Janus Henderson Group PLC London, X016.3MShares$29.6 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$27.9 Million0.5% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.44MShares$17.2 Million0.79% of portfolio
-
Mangrove Partners New York, NY7.79MShares$14.2 Million1.99% of portfolio
-
Abrdn PLC5.54MShares$10.1 Million0.02% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $227M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...